DR REDDYS LABORATORIES
Back to Income Statement
|
DR REDDYS LABORATORIES Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹28,011 Cr | ₹24,670 Cr | ₹21,545 Cr | ₹19,048 Cr | ₹17,517 Cr |
What is the latest Revenue of DR REDDYS LABORATORIES ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹28,011 Cr |
| Mar2024 | ₹24,670 Cr |
| Mar2023 | ₹21,545 Cr |
| Mar2022 | ₹19,048 Cr |
| Mar2021 | ₹17,517 Cr |
How is Revenue of DR REDDYS LABORATORIES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹28,011 Cr | 13.54 | |
| Mar2024 | ₹24,670 Cr | 14.50 | |
| Mar2023 | ₹21,545 Cr | 13.11 | |
| Mar2022 | ₹19,048 Cr | 8.74 | |
| Mar2021 | ₹17,517 Cr | - | |
Compare Revenue of peers of DR REDDYS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR REDDYS LABORATORIES | ₹105,923.4 Cr | -0.5% | -4.7% | -5.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹436,667.0 Cr | 1.4% | -4.5% | 6.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,805.0 Cr | 0.1% | -2.5% | -0.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹150,554.0 Cr | -2.7% | 1.2% | 39.3% | Stock Analytics | |
| CIPLA | ₹109,120.0 Cr | -2.3% | -5.3% | -9.8% | Stock Analytics | |
| MANKIND PHARMA | ₹97,611.6 Cr | -0.3% | -5.3% | -0.9% | Stock Analytics | |
DR REDDYS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR REDDYS LABORATORIES | -0.5% |
-4.7% |
-5.4% |
| SENSEX | 4.3% |
2.6% |
-6.4% |
You may also like the below Video Courses